World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
73
Citations
32150
World Ranking
19538
National Ranking
9726

Overview

David T. Teachey is affiliated with Children's Hospital of Philadelphia in the United States. Their research primarily spans the field of medicine, with significant contributions to subfields including public health, environmental and occupational health, oncology, hematology, molecular biology, and immunology.

Their main topics of study focus on hematologic malignancies and immunotherapy, with key areas including:

  • Acute Lymphoblastic Leukemia research
  • CAR-T cell therapy research
  • Childhood Cancer Survivors' Quality of Life
  • Acute Myeloid Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Chronic Myeloid Leukemia Treatments
  • Chronic Lymphocytic Leukemia Research

Recent impactful papers authored or coauthored by David T. Teachey include:

  • Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2 (2020), published in Journal of Clinical Investigation
  • Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events (2020), Journal for ImmunoTherapy of Cancer
  • Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome (2023), Transplantation and Cellular Therapy
  • Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology (2020), Journal of the National Comprehensive Cancer Network
  • Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared with adult and pediatric COVID-19 (2021), Science Immunology

David T. Teachey has frequently collaborated with several researchers, including:

  • Mignon L. Loh
  • Elizabeth A. Raetz
  • Meenakshi Devidas
  • Caroline Diorio
  • Stephen P. Hunger

Their work has been published extensively in venues such as:

  • Blood
  • Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature
  • Blood Advances
  • Journal of Clinical Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)

Best Publications

  • Chimeric antigen receptor T cells for sustained remissions in leukemia.

    Shannon L. Maude;Noelle Frey;Pamela A. Shaw;Richard Aplenc

  • Chimeric antigen receptor-modified T cells for acute lymphoid leukemia.

    Stephan A. Grupp;Michael Kalos;David Barrett;Richard Aplenc

  • Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo

    Michael C. Milone;Jonathan D. Fish;Jonathan D. Fish;Carmine Carpenito;Richard G. Carroll

  • Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T cell Therapy for Acute Lymphoblastic Leukemia

    David T. Teachey;David T. Teachey;Simon F. Lacey;Pamela A. Shaw;J. Joseph Melenhorst

  • Managing cytokine release syndrome associated with novel T cell-engaging therapies.

    Shannon L. Maude;David Barrett;David T. Teachey;Stephan A. Grupp

  • Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia

    Kathryn G. Roberts;Ryan D. Morin;Jinghui Zhang;Martin Hirst

  • CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia

    Shannon L. Maude;David T. Teachey;David L. Porter;Stephan A. Grupp;Stephan A. Grupp

  • Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia

    Alexis A. Thompson;Mark C. Walters;Janet Kwiatkowski;John E.J. Rasko;John E.J. Rasko;John E.J. Rasko

  • Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy.

    David T. Teachey;David T. Teachey;Susan R. Rheingold;Susan R. Rheingold;Shannon L. Maude;Shannon L. Maude;Gerhard Zugmaier

  • Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop.

    Joao B. Oliveira;Jack J. Bleesing;Umberto Dianzani;Thomas A. Fleisher

  • Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia

    Julie C Fitzgerald;Scott L Weiss;Shannon L Maude;David M Barrett

  • Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2.

    Caroline Diorio;Sarah E. Henrickson;Laura A. Vella;Kevin O. McNerney

  • Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia

    Shannon L. Maude;Shannon L. Maude;Sarah K. Tasian;Sarah K. Tasian;Tiffaney Vincent;Junior W. Hall

  • Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome

    Chelsea Kotch;David Barrett;David T. Teachey

  • T-cell acute lymphoblastic leukemia

    Elizabeth A. Raetz;David T. Teachey

  • Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens

    DeepakBabu Chellapandian;Rupali Das;Kristin Zelley;Susan J. Wiener

  • Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia.

    Shannon L. Maude;Shannon L. Maude;Sibasish Dolai;Cristina Delgado-Martin;Tiffaney Vincent

  • Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia.

    David T Teachey;Ching-Hon Pui

  • Measuring IL-6 and sIL-6R in serum from patients treated with tocilizumab and/or siltuximab following CAR T cell therapy

    Fang Chen;David T. Teachey;Edward Pequignot;Noelle Frey

  • Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS)

    David T. Teachey;Catherine S. Manno;Kelly M. Axsom;Timothy Andrews

Frequent Co-Authors

Stephan A. Grupp
Stephan A. Grupp Children's Hospital of Philadelphia
David M. Barrett
David M. Barrett Children's Hospital of Philadelphia
Stephen P. Hunger
Stephen P. Hunger University of Pennsylvania
Carl H. June
Carl H. June University of Pennsylvania
Mignon L. Loh
Mignon L. Loh University of California, San Francisco
Simon F. Lacey
Simon F. Lacey University of Pennsylvania
David L. Porter
David L. Porter University of Pennsylvania
Bruce L. Levine
Bruce L. Levine University of Pennsylvania
J. Joseph Melenhorst
J. Joseph Melenhorst University of Pennsylvania
Brent L. Wood
Brent L. Wood University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering medicine in the USA opens doors to a range of online degrees and alternative healthcare career pathways. If you’re aiming for a leadership role in healthcare, an accelerated healthcare administration degree lets you fast-track your studies and join the workforce sooner. This flexible option helps you build management skills vital for hospital or clinic settings.

Those in nursing can transition to advanced practice roles through programs like the asn to np track. This type of bridge program is designed for registered nurses who want to become nurse practitioners without starting over, combining practical experience with a boost in credentials.

If your passion lies in dietetics or preventative care, numerous nutrition degrees online are available. These programs focus on the science of food and its impact on health, preparing you for roles in hospitals, public health, or private practice.

For those looking at senior leadership, pursuing a cahme accredited online mha assures a rigorous, industry-approved master’s in healthcare administration. Accreditation ensures your degree meets high standards, making you a strong candidate for executive positions.

Best Scientists Citing David T. Teachey

Trending Scientists

Recently Published Articles